[2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy].
暂无分享,去创建一个
Martin Borggrefe | Giuseppe Limongelli | Frans H Rutten | Christoph Tillmanns | Heiko Mahrholdt | Franco Cecchi | Perry M Elliott | Petros Nihoyannopoulos | Claudio Rapezzi | Stefano Nistri | Burkert Pieske | F. Rutten | M. Borggrefe | P. Nihoyannopoulos | H. Watkins | P. Elliott | A. Hagège | C. Rapezzi | M. Borger | J. Mogensen | B. Pieske | F. Cecchi | G. Limongelli | A. Lafont | A. Anastasakis | H. Mahrholdt | S. Nistri | P. Pieper | Christoph Tillmanns | Hugh Watkins | Michael A Borger | Jens Mogensen | Antoine Lafont | Aris Anastasakis | Petronella G Pieper | Phillippe Charron | Albert Alain Hagege | Wiliam J McKenna | P. Charron | W. McKenna
[1] Giuseppe Limongelli,et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). , 2014, European heart journal.
[2] Johan Duflou,et al. Exome analysis-based molecular autopsy in cases of sudden unexplained death in the young. , 2014, Heart rhythm.
[3] P. Lambiase,et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry , 2014, European heart journal.
[4] Natesa G Pandian,et al. Investigation of Global and Regional Myocardial Mechanics With 3-Dimensional Speckle Tracking Echocardiography and Relations to Hypertrophy and Fibrosis in Hypertrophic Cardiomyopathy , 2014, Circulation. Cardiovascular imaging.
[5] A. Gómez-Outes,et al. Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups , 2013, Thrombosis.
[6] R. D'Alessandro,et al. Skeletal muscle involvement in cardiomyopathies , 2013, Journal of Cardiovascular Medicine.
[7] Jeroen J. Bax,et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.
[8] A. Camm,et al. Left ventricular outflow tract obstruction , 2013 .
[9] L. Appel,et al. Relationship of Left Ventricular Hypertrophy and Diastolic Function With Cardiovascular and Renal Outcomes in African Americans With Hypertensive Chronic Kidney Disease , 2013, Hypertension.
[10] V. Kamperidis,et al. Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction. , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[11] Perry M Elliott,et al. Genetic biomarkers in hypertrophic cardiomyopathy. , 2013, Biomarkers in medicine.
[12] P. Elliott,et al. Systematic review of atrial fibrillation and stroke in patients with hypertrophic cardiomyopathy , 2013 .
[13] Lluís Mont,et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.
[14] S. Ommen,et al. Transapical approach to myectomy for midventricular obstruction in hypertrophic cardiomyopathy. , 2013, The Annals of thoracic surgery.
[15] D. Todd,et al. United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[16] N. Smedira,et al. Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract Obstruction , 2013, Circulation.
[17] M. Sherrid,et al. Treatment of Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Therapy With &bgr;-Blockade or Verapamil , 2013, Circulation. Heart failure.
[18] M. Sherrid,et al. Post-prandial upright exercise echocardiography in hypertrophic cardiomyopathy. , 2013, Journal of the American College of Cardiology.
[19] M. Yacoub,et al. Erratum to: Early Results of Sarcomeric Gene Screening from the Egyptian National BA-HCM Program , 2013, Journal of Cardiovascular Translational Research.
[20] Y. Pinto,et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.
[21] Perry M Elliott,et al. A systematic review and meta-analysis of genotype–phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations , 2013, Heart.
[22] David A Bluemke,et al. Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy. , 2013, Journal of cardiovascular computed tomography.
[23] S. K. White,et al. Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.
[24] M. Link,et al. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. , 2013, Journal of the American College of Cardiology.
[25] J. Vogt,et al. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy. , 2013, The Canadian journal of cardiology.
[26] Eckart Fleck,et al. Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography. , 2013, European heart journal cardiovascular Imaging.
[27] Stefan L. Zimmerman,et al. Relationship of Delayed Enhancement by Magnetic Resonance to Myocardial Perfusion by Positron Emission Tomography in Hypertrophic Cardiomyopathy , 2013, Circulation. Cardiovascular imaging.
[28] A. Dawnay,et al. Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy. , 2013, European heart journal.
[29] B. Schmidt,et al. Epicardial ablation of monomorphic ventricular tachycardia storm in hypertrophic cardiomyopathy. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[30] H. Saal,et al. Ethical and Policy Issues in Genetic Testing and Screening of Children , 2013, Pediatrics.
[31] F. Salvi,et al. Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. , 2013, European heart journal.
[32] Claudia Giambartolomei,et al. Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing , 2013, Journal of Medical Genetics.
[33] T. Betts,et al. Epicardial ablation of monomorphic ventricular tachycardia in a case of hypertrophic cardiomyopathy with apical aneurysm. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[34] Asterios Karagiannis,et al. Efficacy of Various “Classic” Echocardiographic and Laboratory Indices in Distinguishing the “Gray Zone” between Athlete's Heart and Hypertrophic Cardiomyopathy: A Pilot Study , 2013, Echocardiography.
[35] S. Ommen,et al. Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults. , 2013, The Annals of thoracic surgery.
[36] M. Scanavacca,et al. Evaluation of the autonomic function in patients with hypertrophic cardiomyopathy with and without syncope. , 2013, Arquivos brasileiros de cardiologia.
[37] B. Gersh,et al. Comparison of surgical septal myectomy to medical therapy alone in patients with hypertrophic cardiomyopathy and syncope. , 2013, The American journal of cardiology.
[38] K. Siminovitch,et al. Toronto Hypertrophic Cardiomyopathy Genotype Score for Prediction of a Positive Genotype in Hypertrophic Cardiomyopathy , 2013, Circulation. Cardiovascular genetics.
[39] P. Knaapen,et al. Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography. , 2013, European heart journal cardiovascular Imaging.
[40] Mathew G. Wilson,et al. Cardiac adaptation to exercise in adolescent athletes of African ethnicity: an emergent elite athletic population , 2013, British Journal of Sports Medicine.
[41] P. Lambiase,et al. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy , 2013, Heart.
[42] L. Køber,et al. Penetrance of Hypertrophic Cardiomyopathy in Children and Adolescents: A 12-Year Follow-up Study of Clinical Screening and Predictive Genetic Testing , 2013, Circulation.
[43] C. Vosa,et al. Asymmetric septal hypertrophy in patients with severe aortic stenosis: the usefulness of associated septal myectomy. , 2013, The Journal of thoracic and cardiovascular surgery.
[44] C. Wanner,et al. Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease. , 2013, JIMD reports.
[45] E. Bratt,et al. Quality of life in asymptomatic children and adolescents before and after diagnosis of hypertrophic cardiomyopathy through family screening. , 2013, Journal of clinical nursing.
[46] Wojciech Zareba,et al. Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.
[47] B. Gersh,et al. Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy , 2012, Circulation.
[48] L. Jordaens,et al. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. , 2012, Journal of the American College of Cardiology.
[49] Jeroen J. Bax,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.
[50] M. Andreassi,et al. Next generation sequencing in cardiovascular diseases. , 2012, World journal of cardiology.
[51] Matthew M Sumpter,et al. Evidence for risk of cardiomyopathy with hydroxychloroquine , 2012, Lupus.
[52] O. Alfieri,et al. Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.
[53] G. Aquaro,et al. Progression of Myocardial Fibrosis Assessed With Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy , 2012 .
[54] B. Maron,et al. β Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. , 2012, The American journal of cardiology.
[55] S. Colan,et al. Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry. , 2012, American heart journal.
[56] L. Jordaens,et al. Outcome and Complications After Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy: Systematic Review and Meta-Analysis , 2012, Circulation. Heart failure.
[57] D. Mancini,et al. Cardiac transplantation in patients with hypertrophic cardiomyopathy. , 2012, The American journal of cardiology.
[58] J. Pepper,et al. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.
[59] Eloisa Arbustini,et al. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. , 2012, Human molecular genetics.
[60] M. Maron,et al. Controversies in cardiovascular medicine Pharmacological treatment options for hypertrophic cardiomyopathy : high time for evidence , 2012 .
[61] A. Branzi,et al. Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis. , 2012, JACC. Cardiovascular imaging.
[62] M. Abel,et al. Transapical Approach for Apical Myectomy and Relief of Midventricular Obstruction in Hypertrophic Cardiomyopathy , 2012, Journal of cardiac surgery.
[63] A. Angelini,et al. 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. , 2012, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[64] M. Yacoub,et al. Patterns of Disease Progression in Hypertrophic Cardiomyopathy: An Individualized Approach to Clinical Staging , 2012, Circulation. Heart failure.
[65] P. Lambiase,et al. Pregnancy outcome and management of women with an implantable cardioverter defibrillator: a single centre experience. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[66] K P George,et al. Significance of deep T-wave inversions in asymptomatic athletes with normal cardiovascular examinations: practical solutions for managing the diagnostic conundrum , 2012, British Journal of Sports Medicine.
[67] S. Ommen,et al. Assessment of left ventricular outflow gradient: hypertrophic cardiomyopathy versus aortic valvular stenosis. , 2012, JACC. Cardiovascular interventions.
[68] M. Nieminen,et al. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy. , 2012, American journal of hypertension.
[69] B. Firwana,et al. Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy. , 2012, The Cochrane database of systematic reviews.
[70] S. Ommen,et al. Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy. , 2012, The American journal of cardiology.
[71] P. Lambiase,et al. The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[72] A. Gavazzi,et al. A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy , 2012, European heart journal.
[73] C. Kramer,et al. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. , 2012, JACC. Cardiovascular imaging.
[74] P. Elliott,et al. Cardiac Myosin Binding Protein-C Mutations in Families With Hypertrophic Cardiomyopathy: Disease Expression in Relation to Age, Gender, and Long Term Outcome , 2012, Circulation. Cardiovascular genetics.
[75] A. Wilde,et al. Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers. , 2012, European heart journal cardiovascular Imaging.
[76] B. Maron,et al. Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy. , 2012, Progress in cardiovascular diseases.
[77] P. Elliott,et al. Long-Term Outcomes in Hypertrophic Cardiomyopathy Caused by Mutations in the Cardiac Troponin T Gene , 2012, Circulation. Cardiovascular genetics.
[78] H. Madeira,et al. Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population. , 2012, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[79] R. Fogari,et al. Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial , 2012, Diabetic medicine : a journal of the British Diabetic Association.
[80] W. Manning,et al. Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy , 2011, Circulation. Cardiovascular imaging.
[81] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[82] R. D'Alessandro,et al. Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course. , 2012, Future cardiology.
[83] R. Bonow,et al. Cardiac computed tomographic imaging to evaluate myocardial scarring/fibrosis in patients with hypertrophic cardiomyopathy: a comparison with cardiac magnetic resonance imaging , 2012, The International Journal of Cardiovascular Imaging.
[84] D. Atar,et al. Dronedarone in high-risk permanent atrial fibrillation. , 2011, The New England journal of medicine.
[85] Barry J Maron,et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, The Journal of thoracic and cardiovascular surgery.
[86] G. Giannakoulas,et al. Chronotropic incompetence and its relation to exercise intolerance in hypertrophic cardiomyopathy. , 2011, International journal of cardiology.
[87] P. Scuffham,et al. A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy , 2011, Heart.
[88] A. Kobori,et al. Left atrial volume predicts adverse cardiac and cerebrovascular events in patients with hypertrophic cardiomyopathy , 2011, Cardiovascular ultrasound.
[89] G. Ailawadi,et al. Use of a Left Ventricular Assist Device in Hypertrophic Cardiomyopathy , 2011, Journal of cardiac surgery.
[90] C. Semsarian,et al. Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy. , 2011, International journal of cardiology.
[91] P. Elliott,et al. Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry Disease Survey , 2011, Heart.
[92] I. Ranasinghe,et al. Negative ionotropic agents for the treatment of left ventricular outflow tract obstruction due to sigmoid septum and concentric left ventricular hypertrophy. , 2011, Heart, lung & circulation.
[93] T. Kubo,et al. Tissue doppler imaging and plasma BNP levels to assess the prognosis in patients with hypertrophic cardiomyopathy. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[94] L. Mestroni,et al. High-throughput Genotyping Robot-assisted Method for Mutation Detection in Patients With Hypertrophic Cardiomyopathy , 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[95] G. Marcus,et al. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. , 2011, Journal of the American College of Cardiology.
[96] M. Henein,et al. Arrhythmogenic left ventricular apical aneurysm in hypertrophic cardiomyopathy. , 2011, International journal of cardiology.
[97] Michael J Ackerman,et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[98] P. Lambiase,et al. The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy , 2011, Heart.
[99] P. Kirchhof,et al. Management of patients with palpitations: a position paper from the European Heart Rhythm Association. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[100] R. Kim,et al. LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. , 2011, JACC. Cardiovascular imaging.
[101] B. Yashiro,et al. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. , 2011, Journal of the American College of Cardiology.
[102] F. Salvi,et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. , 2011, JACC. Cardiovascular imaging.
[103] P. Pieper,et al. Systematic review of pregnancy in women with inherited cardiomyopathies , 2011, European journal of heart failure.
[104] K. Dou,et al. Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm and sustained ventricular tachycardia: a case report and literature review. , 2011, Chinese medical journal.
[105] T. S. Chee,et al. Prevalence of hypertrophic cardiomyopathy on an electrocardiogram-based pre-participation screening programme in a young male South-East Asian population: results from the Singapore Armed Forces Electrocardiogram and Echocardiogram screening protocol. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[106] G. Kervio,et al. The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. , 2011, European heart journal.
[107] M. Gold,et al. Defibrillation Thresholds in Hypertrophic Cardiomyopathy , 2011, Journal of cardiovascular electrophysiology.
[108] S. Kushwaha,et al. Left Ventricular Assist Device Therapy in Patients With Restrictive and Hypertrophic Cardiomyopathy , 2011, Circulation. Heart failure.
[109] R. Hauer,et al. Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy. , 2011, European heart journal.
[110] Hugo A. Katus,et al. Targeted Next-Generation Sequencing for the Molecular Genetic Diagnostics of Cardiomyopathies , 2011, Circulation. Cardiovascular genetics.
[111] W. Stevenson,et al. Long-Term Outcomes of Combined Epicardial and Endocardial Ablation of Monomorphic Ventricular Tachycardia Related to Hypertrophic Cardiomyopathy , 2011, Circulation. Arrhythmia and electrophysiology.
[112] B. Maron,et al. Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities. , 2011, The American journal of cardiology.
[113] S. Perlman,et al. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA). , 2011, American heart journal.
[114] P. Lambiase,et al. Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[115] D. MacIver. A new method for quantification of left ventricular systolic function using a corrected ejection fraction. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[116] A. Oto,et al. Cyanoacrylate for septal ablation in hypertrophic cardiomyopathy. , 2011, Journal of interventional cardiology.
[117] J. Brugada,et al. Biventricular pacing in hypertrophic obstructive cardiomyopathy: a pilot study. , 2011, Heart rhythm.
[118] M. Schloesser,et al. Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months' follow-up in 19 patients. , 2011, Journal of the American College of Cardiology.
[119] Johanna Kuusisto,et al. Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation , 2011, European Radiology.
[120] P. Pernet,et al. Electrical cardioversion during pregnancy: safe or not? , 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.
[121] Joseph D. Kay,et al. Heart Rate Response During Exercise and Pregnancy Outcome in Women With Congenital Heart Disease , 2011, Circulation.
[122] M. Muiesan,et al. Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice , 2011, Blood pressure.
[123] S. Antonarakis,et al. Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice , 2011, Journal of Medical Genetics.
[124] W. Stevenson,et al. Substrate Characterization and Catheter Ablation for Monomorphic Ventricular Tachycardia in Patients With Apical Hypertrophic Cardiomyopathy , 2011, Journal of cardiovascular electrophysiology.
[125] W. Manning,et al. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy , 2010, Circulation.
[126] 童鸿. Recommendations for Interpretation of 12-lead Electrocardiogram in the Athlete , 2011 .
[127] M. Sherrid,et al. Standing and exercise Doppler echocardiography in obstructive hypertrophic cardiomyopathy: the range of gradients with upright activity. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[128] H. Watkins,et al. Inherited cardiomyopathies. , 2011, The New England journal of medicine.
[129] T. Ohtsuki,et al. Two cases of cerebral embolism caused by apical thrombi in midventricular obstructive cardiomyopathy. , 2011, Internal medicine.
[130] F. Salvi,et al. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[131] Giuseppe Boriani,et al. Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[132] A. Rynkiewicz,et al. Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up. , 2010, European heart journal.
[133] L. Monserrat,et al. Insights into genotype–phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3 , 2010, Heart.
[134] S. Qiao,et al. Follow-up by cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy who underwent percutaneous ventricular septal ablation. , 2010, The American journal of cardiology.
[135] A. Keren,et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2010, European heart journal.
[136] Gregory Y H Lip,et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.
[137] B. Maron,et al. Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.
[138] T. Dickfeld,et al. Defibrillation Threshold Testing in Patients with Hypertrophic Cardiomyopathy , 2010, Pacing and clinical electrophysiology : PACE.
[139] Jeroen J. Bax,et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[140] Eckart Fleck,et al. Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.
[141] Udo Sechtem,et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. , 2010, Journal of the American College of Cardiology.
[142] B. Mulder,et al. Predictors of pregnancy complications in women with congenital heart disease. , 2010, European heart journal.
[143] M. Maron,et al. Survival After Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy , 2010, Circulation. Heart failure.
[144] I. Kowalik,et al. Implantable Cardioverter‐Defibrillator in Patients With Hypertrophic Cardiomyopathy: Efficacy and Complications of the Therapy in Long‐Term Follow‐up , 2010, Journal of cardiovascular electrophysiology.
[145] Agnes Pasquet,et al. Recommendations for transoesophageal echocardiography: update 2010. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[146] W. Toff,et al. Fitness to fly for passengers with cardiovascular disease. , 2010, Heart.
[147] W. Rużyłło,et al. Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy. , 2010, Kardiologia polska.
[148] S. Tezenas du Montcel,et al. Early identification of mutation carriers in familial hypertrophic cardiomyopathy by combined echocardiography and tissue Doppler imaging. , 2010, European heart journal.
[149] A. Angelini,et al. Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy , 2010, European heart journal.
[150] P. Serruys,et al. Long-Term Outcome of Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy: A Word of Caution , 2010, Circulation. Heart failure.
[151] J. Zamorano,et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[152] Michael J Ackerman,et al. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. , 2010, Journal of the American College of Cardiology.
[153] H. Watkins,et al. DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model. , 2010, European heart journal.
[154] D. Mele,et al. Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment , 2010, Cardiovascular ultrasound.
[155] D. Simel,et al. Meta-Analyses of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy: Comparative Rates of Overall Mortality and Sudden Cardiac Death After Treatment , 2010, Circulation. Cardiovascular interventions.
[156] Michel Haissaguerre,et al. Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[157] N. Smedira,et al. Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. , 2010, Journal of the American College of Cardiology.
[158] Matthew W. Martinez,et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. , 2010, JACC. Cardiovascular imaging.
[159] M. Sheppard,et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .
[160] N. Tuseth,et al. Asymmetric septal hypertrophy – a marker of hypertension in aortic stenosis (a SEAS substudy) , 2010, Blood pressure.
[161] A. Tajik,et al. Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy , 2010, Circulation. Heart failure.
[162] J. Towbin,et al. Diagnostic, Prognostic and Therapeutic Implications of Genetic Testing for Hypertrophic Cardiomyopathy , 2010 .
[163] Satoshi Okayama,et al. Role of cardiac computed tomography in planning and evaluating percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. , 2010, Journal of cardiovascular computed tomography.
[164] L. Monserrat,et al. Severe cardiac conduction disturbances and pacemaker implantation in patients with hypertrophic cardiomyopathy. , 2010, Revista espanola de cardiologia.
[165] Nora Toma,et al. An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, Maedica.
[166] G. Boriani,et al. Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. , 2009, The American journal of cardiology.
[167] P. Lambiase,et al. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. , 2009, European heart journal.
[168] C. C. Castro,et al. Late enhancement and myocardial perfusion in hypertrophic cardiomyopathy (comparison between groups). , 2009, Arquivos brasileiros de cardiologia.
[169] A. Wilde,et al. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy. , 2009, Heart rhythm.
[170] M. Sherrid,et al. Severe Symptoms in Mid and Apical Hypertrophic Cardiomyopathy , 2009, Echocardiography.
[171] G. Giannakoulas,et al. Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy. , 2009, The American journal of cardiology.
[172] J. Staessen,et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial , 2009, The Lancet.
[173] E. Arbustini,et al. Heart transplantation in infants with idiopathic hypertrophic cardiomyopathy , 2009, Pediatric transplantation.
[174] J. Le Heuzey,et al. Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[175] B. Gersh,et al. Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study. , 2009, Journal of the American College of Cardiology.
[176] O. Wever-Pinzon,et al. Reflections of inflections in hypertrophic cardiomyopathy. , 2009, Journal of the American College of Cardiology.
[177] N. Smedira,et al. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. , 2009, Journal of the American College of Cardiology.
[178] A. Tajik,et al. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. , 2009, Journal of the American College of Cardiology.
[179] J. Towbin,et al. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. , 2009, Journal of the American College of Cardiology.
[180] S. Siu,et al. Choosing the best contraceptive method for the adult with congenital heart disease , 2009, Current cardiology reports.
[181] D. Corrado,et al. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death. , 2009, European heart journal.
[182] W. Shimizu,et al. QRS prolongation is associated with high defibrillation thresholds during cardioverter-defibrillator implantations in patients with hypertrophic cardiomyopathy. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[183] Salim Yusuf,et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[184] Ana Morales,et al. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2009, Circulation. Heart failure.
[185] D. Sorysz,et al. Left Ventricular Outflow Tract Gradient Provoked by Upright Position or Exercise in Treated Patients with Hypertrophic Cardiomyopathy without Obstruction at Rest , 2009, Echocardiography.
[186] E. Aliot,et al. Indications for the use of diagnostic implantable and external ECG loop recorders. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[187] Matthias Gutberlet,et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .
[188] C. Autore,et al. Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy , 2009, Circulation.
[189] B. Maron,et al. Successful Catheter Ablation of Hemodynamically Unstable Monomorphic Ventricular Tachycardia in a Patient with Hypertrophic Cardiomyopathy and Apical Aneurysm , 2009, Journal of cardiovascular electrophysiology.
[190] B. Gersh,et al. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy , 2009, Heart.
[191] L. Hougs,et al. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives , 2009, Human mutation.
[192] M. P. van den Berg,et al. Family letters are an effective way to inform relatives about inherited cardiac disease , 2009, American journal of medical genetics. Part A.
[193] S. Solomon,et al. Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy , 2009, Circulation.
[194] Arturo Evangelista,et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[195] J. Schulz-Menger,et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. , 2009, Journal of the American College of Cardiology.
[196] Harald Becher,et al. Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[197] B. Maron,et al. Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy , 2009 .
[198] J. Stockman. Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy , 2009 .
[199] J. Stockman. Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry , 2009 .
[200] A. Waldo. Substrate and Procedural Predictors of Outcomes After Catheter Ablation for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy , 2009 .
[201] M. Chiariello,et al. Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[202] Jeroen J. Bax,et al. Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies. , 2008, JACC. Cardiovascular imaging.
[203] B. Gersh,et al. Circadian Rhythm of Appropriate Implantable Cardioverter Defibrillator Discharges in Patients with Hypertrophic Cardiomyopathy , 2008, Pacing and clinical electrophysiology : PACE.
[204] S. Nagueh,et al. Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007. , 2008, JACC. Cardiovascular interventions.
[205] S. Miura,et al. Usefulness of multi-detector row computed tomography for the management of percutaneous transluminal septal myocardial ablation in patient with hypertrophic obstructive cardiomyopathy. , 2008, International journal of cardiology.
[206] Warren J Manning,et al. Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy , 2008, Circulation. Heart failure.
[207] Luigi Rega,et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[208] B. Gersh,et al. Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy , 2008, Circulation.
[209] B. Maron,et al. Relation between training-induced left ventricular hypertrophy and risk for ventricular tachyarrhythmias in elite athletes. , 2008, The American journal of cardiology.
[210] D. Hagler,et al. Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[211] Rachael,et al. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. , 2008, Mayo Clinic proceedings.
[212] M. Digilio,et al. Leopard syndrome , 2008, Orphanet journal of rare diseases.
[213] P. Cordeiro,et al. Evaluation of left ventricular outflow tract gradient during treadmill exercise and in recovery period in orthostatic position, in patients with hypertrophic cardiomyopathy , 2008, Cardiovascular ultrasound.
[214] Eugene H Blackstone,et al. Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. , 2008, The Annals of thoracic surgery.
[215] P. Lambiase,et al. Effect of biventricular pacing on symptoms and cardiac remodelling in patients with end‐stage hypertrophic cardiomyopathy , 2008, European journal of heart failure.
[216] R. Arena,et al. Ventilatory efficiency and resting hemodynamics in hypertrophic cardiomyopathy. , 2008, Medicine and science in sports and exercise.
[217] Heidi L Rehm,et al. Shared genetic causes of cardiac hypertrophy in children and adults. , 2008, The New England journal of medicine.
[218] W. Manning,et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.
[219] K. Klingel,et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.
[220] W. Manning,et al. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, The American journal of cardiology.
[221] Jeroen J. Bax,et al. Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. , 2008, European heart journal.
[222] G. Boriani,et al. Heart transplantation in hypertrophic cardiomyopathy. , 2008, The American journal of cardiology.
[223] L. Trinquart,et al. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. , 2008, European heart journal.
[224] Eloisa Arbustini,et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.
[225] W. Mckenna,et al. Episodic syncope in hypertrophic cardiomyopathy: evidence for inappropriate vasodilation , 2007, Heart.
[226] M. Link,et al. Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction , 2008 .
[227] B. Fivush,et al. Ability of blood pressure to predict left ventricular hypertrophy in children with primary hypertension. , 2008, The Journal of pediatrics.
[228] P. Pellikka,et al. Dynamic left ventricular outflow tract obstruction evoked by exercise echocardiography: prevalence and predictive factors in a prospective study. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[229] N. Smedira,et al. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. , 2008, The Annals of thoracic surgery.
[230] M. Sheppard,et al. Guidelines for autopsy investigation of sudden cardiac death , 2007, Virchows Archiv.
[231] C. Stellbrink,et al. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience , 2008, Clinical Research in Cardiology.
[232] S. Ommen,et al. Evaluation of Left Ventricular Filling Pressures by Doppler Echocardiography in Patients With Hypertrophic Cardiomyopathy: Correlation With Direct Left Atrial Pressure Measurement at Cardiac Catheterization , 2007, Circulation.
[233] A. Keren,et al. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy , 2007, Heart.
[234] Renu Virmani,et al. A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .
[235] S. Kunimoto,et al. Mid-Ventricular Obstructive Hypertrophic Cardiomyopathy Associated with an Apical Aneurysm: Evaluation of Possible Causes of Aneurysm Formation , 2007, Yonsei medical journal.
[236] D. Fassbender,et al. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response , 2007, Clinical Research in Cardiology.
[237] F. Walker,et al. Hyperthrophic obstructive cardiomyopathy and pregnancy: University College London Hospital experience. , 2007, Minerva anestesiologica.
[238] M. Frenneaux,et al. Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[239] B. Gersh,et al. Surgery Insight: septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experience , 2007, Nature Clinical Practice Cardiovascular Medicine.
[240] Lucas M Bachmann,et al. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review , 2007, BMJ : British Medical Journal.
[241] G. Di Salvo,et al. Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. , 2007, The American journal of cardiology.
[242] Mario J. Garcia,et al. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy , 2007, Heart.
[243] D. Fassbender,et al. Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances. , 2007, International journal of cardiology.
[244] P. Elliott,et al. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. , 2007, Journal of the American College of Cardiology.
[245] F. Gaita,et al. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. , 2007, The American journal of cardiology.
[246] P. Shiels,et al. Feasibility study of percutaneous transvalvular endomyocardial cryoablation for the treatment of hypertrophic obstructive cardiomyopathy. , 2007, The Journal of invasive cardiology.
[247] K. Hayashi,et al. Differences in the diagnostic value of various criteria of negative T waves for hypertrophic cardiomyopathy based on a molecular genetic diagnosis. , 2007, Clinical science.
[248] M. ROTH-KLEINER,et al. Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study. , 2007, European heart journal.
[249] B. Maron,et al. Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy , 2007, Heart.
[250] G. Boriani,et al. Electrophysiologic Manifestations of Ventricular Tachyarrhythmias Provoking Appropriate Defibrillator Interventions in High‐Risk Patients with Hypertrophic Cardiomyopathy , 2007, Journal of cardiovascular electrophysiology.
[251] S. Prasad,et al. Use of cardiovascular magnetic resonance for diagnosis and management in hypertrophic cardiomyopathy , 2007, Current cardiology reports.
[252] Zhi-hong Han,et al. [Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy]. , 2007, Zhonghua xin xue guan bing za zhi.
[253] J. Krieger,et al. Influence of pregnancy on clinical course and fetal outcome of women with hypertrophic cardiomyopathy. , 2007, Arquivos brasileiros de cardiologia.
[254] A. Tajik,et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. , 2007, Journal of the American College of Cardiology.
[255] Y. Pinto,et al. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. , 2006, Journal of the American College of Cardiology.
[256] Eloisa Arbustini,et al. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[257] J. Cassiman,et al. Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers , 2006, Clinical genetics.
[258] Barry J Maron,et al. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. , 2006, Circulation.
[259] M. Janabi,et al. Clinical and echocardiographic study of hypertrophic cardiomyopathy in Tanzania , 2006, Tropical doctor.
[260] B. Maron,et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). , 2006, The American journal of cardiology.
[261] J. Pu,et al. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis. , 2006, International journal of cardiology.
[262] J. Zwanenburg,et al. Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: A PET and MRI study , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[263] Stuart Russell,et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[264] P. Elliott,et al. Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy , 2006, Heart.
[265] P. Elliott,et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. , 2006, European heart journal.
[266] W. Manning,et al. Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy , 2006, Circulation.
[267] G. Keren,et al. Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age. , 2006, The American journal of cardiology.
[268] P. Calabrò,et al. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy. , 2006, European heart journal.
[269] L. Monserrat,et al. Magnetic Resonance Imaging of Delayed Enhancement in Hypertrophic Cardiomyopathy: Relationship with Left Ventricular Perfusion and Contractile Function , 2006, Journal of computer assisted tomography.
[270] J. Narula,et al. Review of noninvasive imaging for hypertrophic cardiac syndromes and restrictive physiology. , 2006, Heart failure clinics.
[271] Michael J Ackerman,et al. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. , 2006, Mayo Clinic proceedings.
[272] M. Laakso,et al. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes. , 2006, American heart journal.
[273] S. Themistoclakis,et al. Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. , 2006, Heart rhythm.
[274] W. Mckenna,et al. Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy , 2005, Heart.
[275] W. Frishman. Gender-related Differences in the Clinical Presentation and Outcome of Hypertrophic Cardiomyopathy , 2006 .
[276] D. Holmgren,et al. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly , 2005, Cardiology in the Young.
[277] Seok‐Min Kang,et al. Tissue Doppler-derived indices predict exercise capacity in patients with apical hypertrophic cardiomyopathy. , 2005, Chest.
[278] J. Seidman,et al. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling , 2005, Journal of Medical Genetics.
[279] R. Falk. Diagnosis and Management of the Cardiac Amyloidoses , 2005, Circulation.
[280] J. Carlin,et al. Clinical Features and Outcomes of Childhood Hypertrophic Cardiomyopathy: Results From a National Population-Based Study , 2005, Circulation.
[281] J. Cassiman. Research network: EuroGentest – a European Network of Excellence aimed at harmonizing genetic testing services , 2005, European Journal of Human Genetics.
[282] Michael Jerosch-Herold,et al. Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.
[283] A. Tajik,et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.
[284] B. Maron,et al. Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy. , 2005, Heart rhythm.
[285] B. Maron,et al. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. , 2005, The American journal of cardiology.
[286] W. Mckenna,et al. Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy , 2005, Heart.
[287] A. Tajik,et al. Yield of genetic testing in hypertrophic cardiomyopathy. , 2005, Mayo Clinic proceedings.
[288] W. Williams,et al. Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy , 2005, Circulation.
[289] B. Maron,et al. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.
[290] C. Autore,et al. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. , 2005, Journal of the American College of Cardiology.
[291] P. Elliott,et al. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history. , 2005, Journal of the American College of Cardiology.
[292] B. Maron,et al. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.
[293] P. Verdecchia,et al. Asymptomatic Left Ventricular Systolic Dysfunction in Essential Hypertension: Prevalence, Determinants, and Prognostic Value , 2005, Hypertension.
[294] E. Benedetti,et al. Reversal of tacrolimus‐related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6‐year‐old recipient , 2005, Pediatric transplantation.
[295] Stefan Neubauer,et al. Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. , 2004, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[296] T. Kato,et al. Discrimination of Nonobstructive Hypertrophic Cardiomyopathy From Hypertensive Left Ventricular Hypertrophy on the Basis of Strain Rate Imaging by Tissue Doppler Ultrasonography , 2004, Circulation.
[297] J. Schulz-Menger,et al. Percutaneous Transluminal Septal Artery Ablation Using Polyvinyl Alcohol Foam Particles for Septal Hypertrophy in Patients with Hypertrophic Obstructive Cardiomyopathy: Acute and 3-Year Outcomes , 2004, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[298] M. Nieminen,et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. , 2004, JAMA.
[299] D. Fassbender,et al. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience. , 2004, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[300] I. Ţintoiu,et al. Microcoil embolisation for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy. , 2004, Kardiologia polska.
[301] H. Matsubara,et al. Beneficial effect of cibenzoline on left ventricular pressure gradient with sigmoid septum. , 2004, Circulation journal : official journal of the Japanese Circulation Society.
[302] M. Komajda,et al. Prenatal molecular diagnosis in hypertrophic cardiomyopathy: report of the first case , 2004, Prenatal diagnosis.
[303] L. Armadans,et al. Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications? , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[304] S. Mickelsen,et al. Doppler Evaluation of the Descending Aorta in Patients with Hypertrophic Cardiomyopathy: Potential for Assessing the Functional Significance of Outflow Tract Gradients and for Optimizing Pacemaker Function , 2004, Journal of interventional cardiac electrophysiology.
[305] M. Komajda,et al. Calcified mediastinal haematoma: a rare case of cardiac constriction , 2004, Heart.
[306] Dudley J Pennell,et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.
[307] B. Maron,et al. Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study). , 2004, American Journal of Cardiology.
[308] D. Pennell,et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography , 2004, Heart.
[309] I. Ferrer,et al. Desmin-related myopathy: clinical, electrophysiological, radiological, neuropathological and genetic studies , 2004, Journal of the Neurological Sciences.
[310] M. Carrier,et al. Cardiac transplantation for hypertrophic cardiomyopathy: a valid therapeutic option. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[311] B. Maron,et al. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. , 2004, Journal of Thoracic and Cardiovascular Surgery.
[312] N. Smedira,et al. Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy. , 2004, The American journal of cardiology.
[313] P. Stassano,et al. Mitral valve replacement and limited myectomy for hypertrophic obstructive cardiomyopathy: a 25-year follow-up. , 2004, Texas Heart Institute journal.
[314] R. Hui,et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. , 2004, The American journal of medicine.
[315] F. Girolami,et al. Prevalence and clinical profile of troponin T mutations among patients with hypertrophic cardiomyopathy in tuscany. , 2003, The American journal of cardiology.
[316] B. Godard,et al. Population genetic screening programmes: principles, techniques, practices, and policies , 2003, European Journal of Human Genetics.
[317] D. Pennell,et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. , 2003, European heart journal.
[318] A. Tajik,et al. Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease , 2003, Circulation.
[319] Silvia G Priori,et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co , 2003, Circulation.
[320] A. Tajik,et al. Myocardial bridging in adult patients with hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.
[321] P. Elliott,et al. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.
[322] Erik G. Ellsworth,et al. Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy , 2003, Circulation.
[323] R. Schmieder,et al. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. , 2003, The American journal of medicine.
[324] M. Komajda,et al. Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population. , 2003, International journal of cardiology.
[325] M. S. Hamid,et al. Pregnancy related complications in women with hypertrophic cardiomyopathy , 2003, Heart.
[326] B. Maron,et al. Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy. , 2003, The American journal of cardiology.
[327] Douglas S Lee,et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. , 2003, Journal of the American College of Cardiology.
[328] M. Komajda,et al. Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.
[329] E John Orav,et al. The incidence of pediatric cardiomyopathy in two regions of the United States. , 2003, The New England journal of medicine.
[330] D. Corrado,et al. Screening for hypertrophic cardiomyopathy in a young male military population. , 2003, The American journal of cardiology.
[331] F. T. ten Cate,et al. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. , 2003, Journal of the American College of Cardiology.
[332] O. Havndrup,et al. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. , 2003, Cardiovascular research.
[333] B. Maron,et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.
[334] Provision of genetic services in Europe: current practices and issues , 2003, European Journal of Human Genetics.
[335] Genetic information and testing in insurance and employment: technical, social and ethical issues , 2003, European Journal of Human Genetics.
[336] E. D. Wigle,et al. Expert consensus document American College of Cardiology / European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy , 2003 .
[337] C. Autore,et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[338] H. Dige-Petersen,et al. Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. , 2002, American heart journal.
[339] E. Zackai,et al. Further delineation of cardiac abnormalities in Costello syndrome. , 2002, American journal of medical genetics.
[340] N. Cardim,et al. Usefulness of Doppler myocardial imaging for identification of mutation carriers of familial hypertrophic cardiomyopathy. , 2002, The American journal of cardiology.
[341] D. Rao,et al. Associations between angiotensinogen gene variants and left ventricular mass and function in the HyperGEN study. , 2002, American heart journal.
[342] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.
[343] B. Maron,et al. Remodeling of Left Ventricular Hypertrophy in Elite Athletes After Long-Term Deconditioning , 2002, Circulation.
[344] J. Staessen,et al. Relationship Between Treatment-Induced Changes in Left Ventricular Mass and Blood Pressure in Black African Hypertensive Patients: Results of the Baragwanath Trial , 2002, Circulation.
[345] B. Maron,et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[346] Wigle Ed,et al. The diagnosis of hypertrophic cardiomyopathy , 2001, Heart.
[347] B. Maron,et al. Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.
[348] S. Kato,et al. Transient ventricular wall thickening in acute myocarditis: a serial echocardiographic and histopathologic study. , 2001, Japanese circulation journal.
[349] S. Siu,et al. Prospective Multicenter Study of Pregnancy Outcomes in Women With Heart Disease , 2001, Circulation.
[350] M. Quiñones,et al. Tissue Doppler Imaging Consistently Detects Myocardial Abnormalities in Patients With Hypertrophic Cardiomyopathy and Provides a Novel Means for an Early Diagnosis Before and Independently of Hypertrophy , 2001, Circulation.
[351] A. Fraser,et al. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. , 2001, The American journal of cardiology.
[352] R. Elles,et al. Integrated regional genetic services: current and future provision. , 2001, BMJ : British Medical Journal.
[353] M. Hennersdorf,et al. Arterial hypertension and cardiac arrhythmias , 2001, Journal of hypertension.
[354] P. Elliott,et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.
[355] W. Williams,et al. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. , 2000, Journal of the American College of Cardiology.
[356] L. Fananapazir,et al. Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease. , 2000, Journal of the American College of Cardiology.
[357] W. Mckenna,et al. Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. , 2000, Journal of the American College of Cardiology.
[358] W. Mckenna,et al. Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. , 2000, The American journal of cardiology.
[359] B. Maron,et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[360] C. Wippermann,et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe , 2000, Heart.
[361] M. Decristofaro,et al. Hypertrophic cardiomyopathy in pediatric patients: effect of verapamil on regional and global left ventricular diastolic function. , 2000, The Canadian journal of cardiology.
[362] J. Stauffer,et al. Subaortic obstruction after sildenafil in a patient with hypertrophic cardiomyopathy. , 1999, The New England journal of medicine.
[363] K. Borisov,et al. Management of Symptomatic Hypertrophic Obstructive Cardiomyopathy - Long-Term Results after Surgical Therapy , 1999, The Thoracic and cardiovascular surgeon.
[364] M. Josephson,et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). , 1999, Circulation.
[365] B. Maron,et al. Hypertrophic Cardiomyopathy Prognostic Value of Systemic Blood Pressure Response During Exercise in a Community-Based Patient Population With Hypertrophic Cardiomyopathy , 2016 .
[366] B. Maron,et al. Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities. , 1999, Journal of the American College of Cardiology.
[367] P. Elliott,et al. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. , 1999, Journal of the American College of Cardiology.
[368] C. Autore,et al. Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis. , 1999, Circulation.
[369] S. Ward,et al. Diagnostic utility of metabolic exercise testing in a patient with cardiovascular disease , 1999, Heart.
[370] 小橋 文香. Solitary papillary muscle hypertrophy as a possible form of hypertrophic cardiomyopathy , 1999 .
[371] I. Olivotto,et al. Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy. , 1999, Giornale italiano di cardiologia.
[372] B. Andersson,et al. High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate. , 1999, European heart journal.
[373] B. Maron,et al. Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle. , 1998, Circulation.
[374] U. Gleichmann,et al. Outflow Acceleration Assessed by Continuous-Wave Doppler Echocardiography in Left Ventricular Hypertrophy: An Analysis of 103 Consecutive Cases , 1998, Cardiology.
[375] U. Gleichmann,et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. , 1998, Circulation.
[376] T. Imaizumi,et al. Predictors of sudden cardiac death in hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.
[377] M. Komajda,et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. , 1998, European heart journal.
[378] D. Corrado,et al. Screening for hypertrophic cardiomyopathy in young athletes. , 1998, The New England journal of medicine.
[379] A. Kisanuki,et al. Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. , 1998, Circulation.
[380] M. Verani,et al. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. , 1998, Journal of the American College of Cardiology.
[381] O. Hess,et al. Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy. , 1998, The Annals of thoracic surgery.
[382] H Niimura,et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. , 1998, The New England journal of medicine.
[383] B. Maron,et al. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population , 1998, Heart.
[384] C. M. Lowe,et al. Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome. , 1998, European heart journal.
[385] B. Grubb,et al. Implantable cardioverter-defibrillators in children: a single-institutional experience. , 1998, The Annals of thoracic surgery.
[386] M. Komajda,et al. Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy. , 1998, European heart journal.
[387] P. Hanrath,et al. Hypertrophic obstructive cardiomyopathy. , 1998, Advances in cardiac surgery.
[388] W. Mckenna,et al. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. , 1997, Circulation.
[389] R. Michler,et al. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. , 1997, The Journal of thoracic and cardiovascular surgery.
[390] W. Mckenna,et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. , 1997, European heart journal.
[391] M. Komajda,et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. , 1997, Circulation.
[392] H. Watkins,et al. Sudden death due to troponin T mutations. , 1997, Journal of the American College of Cardiology.
[393] J. Schläpfer,et al. Dual Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy: Beneficial Effect of Atrioventricular Junction Ablation for Optimal Left Ventricular Capture and Filling , 1997, Pacing and clinical electrophysiology : PACE.
[394] Y. Fujio,et al. Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy. , 1997, Journal of molecular and cellular cardiology.
[395] A. Tajik,et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. , 1997, Journal of the American College of Cardiology.
[396] W. Mckenna,et al. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. , 1997, Heart.
[397] I. Kronzon,et al. The effect of the ingestion of ethanol on obstruction of the left ventricular outflow tract in hypertrophic cardiomyopathy. , 1996, The New England journal of medicine.
[398] G Campanella,et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. , 1996, American journal of human genetics.
[399] A. Tajik,et al. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. , 1996, Circulation.
[400] B. Maron,et al. Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes. , 1996, JAMA.
[401] W. Mckenna,et al. Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study. , 1996, European heart journal.
[402] David,et al. Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. , 1996, Journal of the American College of Cardiology.
[403] R. Schmieder,et al. Reversal of Left Ventricular Hypertrophy in Essential Hypertension: A Meta-analysis of Randomized Double-blind Studies , 1996 .
[404] J. Skoularigis,et al. Pheochromocytoma associated with clinical and echocardiographic features simulating hypertrophic obstructive cardiomyopathy. , 1996, Chest.
[405] P. Nihoyannopoulos,et al. Symptoms of hypertrophic cardiomyopathy, with special emphasis on syncope and postprandial exacerbation of symptoms , 1996, Clinical cardiology.
[406] R. Robbins,et al. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. , 1996, The Journal of thoracic and cardiovascular surgery.
[407] P. Poole‐Wilson,et al. Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy. , 1996, Heart.
[408] A. Camm,et al. DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience. , 1996, Heart.
[409] N. Obuchowski,et al. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: presurgical and postsurgical evaluation by computed tomography magnetic resonance imaging. , 1996, American journal of cardiac imaging.
[410] B. Maron,et al. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.
[411] B. Maron,et al. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. , 1995, Journal of the American College of Cardiology.
[412] F. Flachskampf,et al. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. , 1995, Circulation.
[413] W. Williams,et al. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. , 1995, Circulation.
[414] J. Gardin,et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.
[415] U. Sigwart. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy , 1995, The Lancet.
[416] David P Miller,et al. Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results , 1995 .
[417] S. Ito,et al. Transesophageal echocardiographic evaluation of mitral regurgitation in hypertrophic cardiomyopathy: contributions of eccentric left ventricular hypertrophy and related abnormalities of the mitral complex. , 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[418] J. Seidman,et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.
[419] G. Koren,et al. Pregnancy outcome after gestational exposure to amiodarone in Canada. , 1995, American journal of obstetrics and gynecology.
[420] James D. Thomas,et al. 763-5 Provocation of Latent Left Ventricular Outflow Tract Gradients with Amyl Nitrite and Exercise in Patients with Hypertrophic Cardiomyopathy , 1995 .
[421] C. Autore,et al. Prognosis of Asymptomatic Patients With Hypertrophic Cardiomyopathy and Nonsustained Ventricular Tachycardia , 1994, Circulation.
[422] M. Proschan,et al. Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports. , 1994, The American journal of cardiology.
[423] K. Berg,et al. The effects of anabolic steroids on myocardial structure and cardiovascular fitness. , 1993, Medicine and science in sports and exercise.
[424] J. Cox,et al. Treatment of cardiac arrhythmias during pregnancy. , 1993, Progress in cardiovascular diseases.
[425] M. Panja,et al. Aortic regurgitation in hypertrophic cardiomyopathy. , 1993, The Journal of the Association of Physicians of India.
[426] M A Proschan,et al. Echocardiographic Assessment of Mitral Valve Size in Obstructive Hypertrophic Cardiomyopathy Anatomic Validation From Mitral Valve Specimen , 1993, Circulation.
[427] B. Maron,et al. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. , 1993, British heart journal.
[428] J. Wodniecki,et al. Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy. , 1993, Cardiology.
[429] B. Maron,et al. Initial Results of Combined Anterior Mitral Leaflet Plication and Ventricular Septal Myotomy‐Myectomy for Relief of Left Ventricular Outflow Tract Obstruction in Patients With Hypertrophic Cardiomyopathy , 1992, Circulation.
[430] E. Rosenkranz,et al. Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy. , 1992, Journal of the American College of Cardiology.
[431] W. Williams,et al. Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making. , 1992, Journal of the American College of Cardiology.
[432] R. Cannon,et al. Predictors of exercise benefit after operative relief of left ventricular outflow obstruction by the myotomy-myectomy procedure in hypertrophic cardiomyopathy. , 1992, The American journal of cardiology.
[433] P. Nihoyannopoulos,et al. Investigation of a Hemodynamic Basis for Syncope in Hypertrophic Cardiomyopathy: Use of a Head‐Up Tilt Test , 1992, Circulation.
[434] W. Roberts,et al. Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy. , 1992, Journal of the American College of Cardiology.
[435] W. Roberts,et al. Anomalous Insertion of Papillary Muscle Directly Into Anterior Mitral Leaflet in Hypertrophic Cardiomyopathy: Significance in Producing Left Ventricular Outflow Obstruction , 1991, Circulation.
[436] D. Webb,et al. Abnormal Vascular Responses to Supine Exercise in Hypertrophic Cardiomyopathy , 1991, Circulation.
[437] R. E. Clark,et al. Aortic regurgitation after left ventricular myotomy and myectomy. , 1991, The Annals of thoracic surgery.
[438] J R Wilson,et al. Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.
[439] M. Proschan,et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. , 1991, The New England journal of medicine.
[440] M. Frenneaux,et al. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. , 1990, Circulation.
[441] B. Marino,et al. Hypertrophic obstructive cardiomyopathy and infective endocarditis: a report of seven cases and a review of the literature. , 1990, European heart journal.
[442] M. Frenneaux,et al. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. , 1990, Journal of the American College of Cardiology.
[443] W. Roberts,et al. Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass. , 1990, British heart journal.
[444] M. Cheitlin,et al. Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy. , 1990, The American journal of cardiology.
[445] A. Keren,et al. The effect of disopyramide on uterine contractions during pregnancy. , 1990, American journal of obstetrics and gynecology.
[446] R O Bonow,et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. , 1989, Circulation.
[447] Z. Krajcer,et al. Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients. , 1989, Circulation.
[448] T. Shiota,et al. Aortic regurgitation associated with hypertrophic cardiomyopathy: a colour Doppler echocardiographic study. , 1989, British heart journal.
[449] L. Melton,et al. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. , 1989, Circulation.
[450] W. Williams,et al. Aortic Regurgitation: A Common Complication After Surgery for Hypertrophic Obstructive Cardiomyopathy , 1989, Journal of the American College of Cardiology.
[451] B. Maron,et al. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. , 1989, Journal of the American College of Cardiology.
[452] R. Bonow,et al. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. , 1989, Circulation.
[453] W. Mckenna,et al. Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: association with left ventricular apical aneurysm. , 1989, British heart journal.
[454] K. Peterson,et al. Hypertrophic cardiomyopathy and sudden death. , 1988, The New England journal of medicine.
[455] N. Kaplan. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. , 1988, The New England journal of medicine.
[456] J. Hradec,et al. The nature of cardiac hypertrophy in acromegaly: an echocardiographic study. , 1988, Cor et vasa.
[457] H. Rakowski,et al. Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy. , 1988, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[458] R. Bonow,et al. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. , 1987, Journal of the American College of Cardiology.
[459] M. Kaltenbach,et al. Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy. , 1987, Zeitschrift fur Kardiologie.
[460] T. Sakamoto,et al. Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening. , 1987 .
[461] M. Webb-Peploe,et al. Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy. , 1986, British heart journal.
[462] W. Mckenna,et al. Variability of ventricular arrhythmias in hypertrophic cardiomyopathy and implications for treatment. , 1986, The American journal of cardiology.
[463] Y. Koga,et al. Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study. , 1986, Japanese heart journal.
[464] B. Maron,et al. Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance. , 1986, Journal of the American College of Cardiology.
[465] A. Castellanos,et al. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.
[466] R. Bonow,et al. Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy. , 1985, Circulation.
[467] W. Williams,et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. , 1985, Progress in cardiovascular diseases.
[468] J. Dussaule,et al. Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study. , 1985, American heart journal.
[469] C. Oakley,et al. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. , 1985, British heart journal.
[470] R. Bonow,et al. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy. , 1985, The American journal of cardiology.
[471] R. Bonow,et al. The acute and chronic effects of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy. , 1983, European heart journal.
[472] W. McKenna,et al. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. , 1983, Journal of the American College of Cardiology.
[473] A. Rocchini,et al. Hemodynamic Effects of Verapamil in Children and Adolescents with Hypertrophic Cardiomyopathy , 1983, Circulation.
[474] J. Goodwin,et al. Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs. , 1982, British heart journal.
[475] R. Bonow,et al. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. , 1981, The American journal of cardiology.
[476] S. Epstein,et al. Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy. , 1981, Circulation.
[477] J. Gottdiener,et al. Hypertrophic Cardiomyopathy with Unusual Locations of Left Ventricular Hypertrophy Undetectable, by M‐mode Echocardiography: Identification by Wide‐angle Two‐dimensional Echocardiography , 1981, Circulation.
[478] M. Davies,et al. Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. , 1980, British heart journal.
[479] B. Maron,et al. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. , 1980, Clinical and investigative medicine. Medecine clinique et experimentale.
[480] B. Maron,et al. Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. , 1979, Circulation.
[481] W. Henry,et al. Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. , 1978, Circulation.
[482] R. Leachman,et al. Mitral valve replacement for idiopathic hypertrophic subaortic stenosis. Results in 27 patients. , 1976, The Journal of cardiovascular surgery.
[483] W. Henry,et al. Operative Treatment in Hypertrophic Subaortic Stenosis: Techniques, and the Results of Pre and Postoperative Assessments in 83 Patients , 1975, Circulation.
[484] M. Dunn,et al. Anterior‐Superior Displacement of Papillary Muscles Producing Obstruction and Mitral Regurgitation in Idiopathic Hypertrophic Subaortic Stenosis: Operative Relief by Posterior‐Superior Realignment of Papillary Muscles Following Ventricular Septal Myectomy , 1974, Circulation.
[485] E. W. Hancock,et al. Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy. , 1973, The American journal of cardiology.
[486] R. Balcon,et al. Syncope in hypertrophic obstructive cardiomyopathy due to asystole. , 1972, British heart journal.
[487] R. Gramiak,et al. Long-term propranolol therapy in muscular subaortic stenosis. , 1970, British heart journal.
[488] E. W. Hancock,et al. Muscular Subaortic Stenosis: Prevention of Outflow Obstruction with Propranolol , 1968, Circulation.
[489] C. Lambrew,et al. Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients , 1964, Circulation.
[490] E. Braunwald,et al. Studies on Digitalis: V. Comparison of the Effects of Ouabain on Left Ventricular Dynamics in Valvular Aortic Stenosis and Hypertrophic Subaortic Stenosis , 1962, Circulation.